US Patent Issued to Regeneron Pharmaceuticals on June 9 for "Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation" (New York Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,031, issued on June 9, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation" was invented by Nilsen Miller (East Greenbush, N.Y.) and Trevor Langley (Rensselaer, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating an eye disorder in a patient that may include administering a medicament to the patient with a prefilled syringe, wherein the administration of the medicament with the prefilled syringe is configured to treat the eye disorder and decrease a rate of likelihood of an ocular infection to the patient's eye."

The patent...